Michael A Egan

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignees: Carco Development Company, Wyeth, Other. Active years: 1994-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael A Egan. Retrieved from https://idiyas.com/inventor/michael-a-egan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 30(Granted Patents)

Location History:

Savannah, GA (US) (1994 - 2004)
Washingtonville, NY (US) (2014)

Company Filing History:

1 out of 1

Carco Development Company

4 out of 834,601

Other

patents

Years Active: 1994-2014

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8623382 - Immunogenic compositions for inducing an immune response to HIV (2014-01-07),

2. 6694670 - Transportable turf grasses and grass sports surfaces having porous foundations (2004-02-24),

3. 6532697 - Production of sod using a soil-less sand based root zone medium (2003-03-18),

4. 6334275 - Sports surfaces and methods of preparing sports surfaces comprising a transportable turf grass (2002-01-01),

5. 5651213 - Production of sod using a soil-less sand based root medium (1997-07-29),

6. 5301466 - Production of sod using a soil-less sand based root zone medium (1994-04-12),

Title: Michael A Egan: Innovator in Immunization Techniques

Introduction

Michael A Egan is a notable inventor in the field of immunization techniques. He has contributed to the development of methods that enhance antigen-specific immune responses in mammals. His work is particularly significant in the context of vaccine development and therapeutic treatments.

Latest Patents

Michael A Egan holds a patent titled "Plasmid DNA In Combination With Recombinant VSV For Use In Prime-Boost Immunization Regimens." This patent describes a method of inducing an immune response by administering a DNA plasmid encoding an antigen and a recombinant vesicular stomatitis virus (rVSV) that also encodes the antigen. The method aims to improve immunization regimens and includes kits for practical application in therapeutic treatments.

Career Highlights

Egan has worked at Wyeth, a company known for its contributions to pharmaceuticals and vaccines. His innovative approach to immunization has positioned him as a key figure in the field, despite having no patents listed under his name.

Collaborations

Michael A Egan has collaborated with notable coworkers such as John Hayward Eldridge and Zimra R Israel. These partnerships have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Michael A Egan's work in immunization techniques showcases his commitment to advancing medical science. His innovative methods have the potential to significantly impact vaccine development and therapeutic treatments.

Profile summary based on public USPTO records.